R. Perdrisot

Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial

Valérie Vilgrain, Héléna Pereira, Eric Assenat et al. · The Lancet Oncology · 2017 · 826 citations

Medicine, Oncology, Radiation Oncology +16

¹⁸F-FDG PET Uptake Characterization Through Texture Analysis: Investigating the Complementary Nature of Heterogeneity and Functional Tumor Volume in a Multi–Cancer Site Patient Cohort

Mathieu Hatt, Mohamed Majdoub, Martin Vallières et al. · Journal of Nuclear Medicine · 2014 · 436 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Visual Versus Quantitative Assessment of Intratumor ¹⁸F-FDG PET Uptake Heterogeneity: Prognostic Value in Non–Small Cell Lung Cancer

Florent Tixier, Mathieu Hatt, Clémence Valla et al. · Journal of Nuclear Medicine · 2014 · 139 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Development of a nomogram combining clinical staging with 18F-FDG PET/CT image features in non-small-cell lung cancer stage I–III

Marie-Charlotte Desseroit, Dimitris Visvikis, Florent Tixier et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2016 · 109 citations · Full text

Medicine, Nuclear Medicine, Oncology +12

Diagnosis of Medullary Carcinoma of the Thyroid (MCT) by Calcitonin Assay Using Monoclonal Antibodies: Criteria for the Pentagastrin Stimulation Test in Hereditary MCT

Denis Guilloteau, R. Perdrisot, C Calmettes et al. · The Journal of Clinical Endocrinology & Metabolism · 1990 · 67 citations

Medicine, Endocrinology, Pathology +9